Raremark joins London Stock Exchange ELITE program
London, UK – November 14, 2018. Raremark has today joined the London Stock Exchange Group’s ELITE program, an ecosystem designed to help private companies prepare and structure for the next stage of growth.
Over the next 12 months, Raremark will receive specialist business education from Imperial College London, as well as advice across a range of areas, including: strategic planning; talent; governance; and preparing for investment.
There are approximately 1,000 companies in the international ELITE community.
Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development, while aiding discoveries which could lead to new treatments. Raremark’s purpose is to create a future in which rare medical conditions are as recognized as the common.
The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and to find new ones. Raremark is headquartered in London, UK with an office in Boston, US. Visit: www.raremark.com
ELITE is the London Stock Exchange Group’s international business support and capital-raising program for ambitious and fast-growing companies. ELITE is an ecosystem designed to help ambitious companies scale up, structure for growth and be more competitive in the global marketplace. ELITE combines education, business support, mentoring and access to expertise and funding. Visit: https://www.lseg.com/elite
Sign up for updates
If you’re an industry professional and would like to subscribe to updates from our research team, including our research projects and our Rare Opinion blog, fill in your details below and we’ll add you to our mailing list.